Clinically Proven, NHS Trusted, Transforming Postpartum Health

The Evidence-Based Digital Solution Recommended by Healthcare Professionals and Valued by Patients

NHS Partnerships

Working Closely with the NHS

Contracted by the NHS 2025
NHS Innovation Accelerator (NIA)

Clinical Studies and Research

Clinically proven results

NHS Evaluation Report
NHS Clinical Trial

Clinical Evidence: Outcomes by Symptom

Urinary incontinence

of women with bladder symptoms improved after using MUTU System*

improvement by Week 6 in NHS patients*

Statistically significant symptom reduction***

Confirmed by real-world customer data

of MUTU System users reported improvement in symptoms within 12 weeks**

Pelvic Organ Prolapse

of women with prolapse symptoms improved after using MUTU System*

of NHS patients reported improvement by Week 3*

Confirmed by real-world customer data

of MUTU System users reported improvement in symptoms within 12 weeks**

Painful Sex (Dyspareunia)

of women improved painful sex symptoms*

of NHS patients reported improvement by Week 3*

Confirmed by real-world customer data

of MUTU System users reported improvement in symptoms within 12 weeks**

Diastasis Recti

of women reported improvement in abdominal separation*

of NHS patients reported improvement by Week 3*

Confirmed by real-world customer data

of MUTU System users reported improvement in symptoms within 12 weeks**

Maternal Mental Health

said pelvic health issues affected their mental health*

reported mental health improvement by 12 weeks*

Statistically significant symptom reduction***

Confirmed by real-world customer data

of MUTU System users reported improvement in symptoms within 12 weeks**

Economic Impact for Healthcare Providers

Cost savings

Every £1 invested inMUTU System…

delivers £1.50 return on investment for NHS maternity services.

£1,400-£1,600

Estimated annual NHS savings per patient

Estimated NHS savings per patient annually by reducing urinary incontinence and pelvic organ prolapse interventions.

System-Wide Benefits

Faster rehabilitation

Reduces burden on primary and secondary healthcare services.

Digital
delivery

increases access and scalability.

Patient Voice andHealth Equity Benefits

of NHS physiotherapy patients would recommend MUTU System*

of NHS GP patients would recommend MUTU System***

Patient Feedback

Expert Feedback

Endorsed by healthcare professionals

Here are endorsements from MUTU System’s Medical Ambassadors, highlighting the program’s effectiveness and their personal experiences:

Industry Partnerships

MUTU System is proud to partner with TENA, the globally recognised leader in continence management and intimate health care. This strategic collaboration reflects a shared commitment to raising awareness, reducing stigma, and improving support for pelvic health in women—particularly during the critical postpartum period.

The partnership supports aligned goals in education, advocacy, and access to solutions for women experiencing pelvic floor dysfunction, incontinence, or prolapse symptoms.

MUTU and TENA are bridging the gap between clinical understanding and accessible, evidence-based self-management tools, empowering women through trusted expertise and high-impact support.

Corporate Health Initiatives

MUTU is implemented in employee wellbeing and maternity return-to-work programmes, helping improve retention and satisfaction among new parent employees. Examples include:

Postpartum Plan

Integrated support programme for new parents via employee wellness.

Heka

An employee wellbeing platform offering MUTU as part of holistic corporate care solutions.

International Partnerships

MUTU System operates international strategic collaborations:

Optum Now / UnitedHealth Group

MUTU has met medical and legal due diligence for inclusion on Optum Now, UHG’s digital health platform. This enables MUTU access through one of the U.S.’s largest employer and healthcare ecosystems, demonstrating compliance with rigorous standards.

Startup Health

MUTU is part of Startup Health’s global innovation portfolio, recognising its impact in women’s health and digital care delivery. This inclusion validates MUTU’s credibility and visibility among global health investors and care leaders.

Compliance, Security, and Industry Recognition

ORCHA (Organisation for the Review of Care and Health Apps), highlighting MUTU’s rigorous standards as a trusted digital health solution.

Why MUTU is Unique

MUTU System is supported not only by clinical trials but also by independent NHS evaluation—such as the 2024 NHS Kent Surrey Sussex Health Innovation Network report—highlighting its significant impact and value as a digital maternal health intervention.

MUTU System stands apart from other postpartum solutions in key areas that matter most to healthcare professionals and decision-makers:

  • Clinical Credibility: Clinically validated through independent NHS trials, including a 2022 study with Norfolk & Norwich University Hospital NHS Trust. This level of medical evidence is rarely seen in consumer-facing postpartum programs.

  • Evidence-Based Results: Quantified symptom improvements across multiple studies and real-world data, including pelvic floor recovery, diastasis recti improvement, reduced pain, and enhanced emotional wellbeing.

  • NHS Partnerships: A unique, proven track record of formal collaboration with the NHS, including a 2025 contract with Kent and Medway NHS and recognition through the NHS Innovation Accelerator.

  • Compliance Standards: Fully accredited with DTAC, GDPR, and ORCHA certifications—ensuring digital safety, regulatory integrity, and trustworthiness for commissioners and clinicians.

  • Expert Leadership: MUTU System was founded by Wendy Powell, a recognised leader in women’s health innovation and an NHS Innovation Accelerator Fellow (2021). Wendy is an internationally respected speaker and advocate for pelvic health, with over a decade of work influencing maternity care policy and innovation.

This unique combination of clinical evidence, institutional trust, expert leadership, and user-friendly accessibility positions MUTU as the most credible and impactful solution in the postpartum care space.

Medical Professionals: Ready to Recommend MUTU?

FAQs for healthcare professionals

You can refer to try MUTU directly via our website. When signing up they will get a free trial before purchase is completed. If you’re looking to procure or commission MUTU for your hospital, clinics or healthcare system, please contact us.

To discuss commissioning or working with us for your NHS Trust, PPHS services, clinic, hospital or region, please contact our NHS Partnerships Lead, Ben Hulme at Hulme Redwood.

To discuss working with us as an Ambassador, please get in touch with Wendy, NIA Fellow and Director at MUTU.

Data sources

* MUTU NHS Clinical Trial View source >

** Findings confirmed by real-world customer data (n=12,000+). Self-reported outcomes are based on surveys completed by MUTU System users at 3, 6, and 12 weeks during the program (2021-2025) View source >

*** NHS Evaluation of MUTU View source >

Download Full NHS Evaluation

To download the full report, complete the form below:

[loading]